Related content

Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy

By Tuttle Todd   Zhang Yan   Greeno Edward   Knutsen Amy  

Annals of Surgical Oncology, Vol. 13, Iss. 12, 2006-12 ,pp. : 1627-1632

Springer Publishing Company

Access to resources Recommend Favorite

Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Asian Perspective

By Tan Winson   Wong Joelle   Chia Claramae   Tan Grace   Soo Khee   Teo Melissa  

Annals of Surgical Oncology, Vol. 20, Iss. 13, 2013-12 ,pp. : 4219-4223

Springer Publishing Company

Access to resources Recommend Favorite

Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin

By Witkamp A.J.   de Bree E.   Kaag M.M.   Boot H.   Beijnen J.H.   van Slooten G.W.   van Coevorden F.   Zoetmulder F.A.N.  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 979-984

Elsevier

Access to resources Recommend Favorite

Morbidity and Mortality Assessment of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma—A Prospective Study of 70 Consecutive Cases

By Yan Tristan   Edwards Gary   Alderman Robert   Marquardt Christina   Sugarbaker Paul  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 515-525

Springer Publishing Company

Access to resources Recommend Favorite

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival in Selected Patients with Peritoneal Carcinomatosis from Abdominal and Pelvic Malignancies: Results of 21 Cases

By Yang Xiao-Jun  

Annals of Surgical Oncology, Vol. 16, Iss. 2, 2009-02 ,pp. : 345-351

Springer Publishing Company

Access to resources Recommend Favorite